The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levetiracetam ER
Levetiracetam · LEVETIRACETAM 750 mg/1 · Tablet, Film Coated, Extended Release · Oral · Proficient Rx LP
NDC 71205-0881-00 · 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 50474-0599-66) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$12.70per unit
middle half $12.70–$12.70 · 2 plans · Jul 1, 2024
Est. net of rebatesⓘ
≈ $12.70
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
—of plans cover it
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 3 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for levetiracetam (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Proficient Rx LPUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA205130
- TE code
- AB
- Approval date
- Nov 27, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Levetiracetam (Tablet, Film Coated, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Proficient Rx LP | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Apotex Corp. | LEVETIRACETAM 1000 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | LEVETIRACETAM 750 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals, Inc | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals, Inc | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco healthcare U.S., LLC | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco healthcare U.S., LLC | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| UCB Pharma S.A. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| UCB Pharma S.A. | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| UCB, Inc. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| UCB, Inc. | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Levetiracetam ER — NDC 71205-0881-00," retrieved September 3, 2026, https://drugdashboards.com/drug/71205088100.
Free to cite with attribution — see how the data is put together.